News Archives - Page 2 of 3 - Voltron Therapeutics

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program

Monalisa Moody2023-04-05T13:57:16-04:00

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio [...]

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology ProgramMonalisa Moody2023-04-05T13:57:16-04:00

Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times

Monalisa Moody2023-04-05T12:09:16-04:00

Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. [...]

Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York TimesMonalisa Moody2023-04-05T12:09:16-04:00

Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19

stephen2021-03-30T21:55:49-04:00

Voltron Therapeutics, Inc. Announces Positive Data from Animal [...]

Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19stephen2021-03-30T21:55:49-04:00

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.

stephen2021-03-03T16:58:40-05:00

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. [...]

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.stephen2021-03-03T16:58:40-05:00

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”

Daniel Malowany2020-08-25T17:47:59-04:00

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge [...]

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”Daniel Malowany2020-08-25T17:47:59-04:00

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19

danny2020-07-09T16:20:15-04:00

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling [...]

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19danny2020-07-09T16:20:15-04:00

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary

danny2020-07-09T16:08:48-04:00

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore [...]

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiarydanny2020-07-09T16:08:48-04:00

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine

News, press release

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine

danny2020-06-11T12:42:24-04:00

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement [...]

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccinedanny2020-06-11T12:42:24-04:00